Neutral endopeptidase inhibitors blunt kidney fibrosis by reducing myofibroblast formation

Roel Bijkerk, Marina A. Aleksinskaya, Jacques M. G. J. Duijs, Jennifer Veth, Bettina Husen, Dania Reiche, Cornelia Prehn, Jerzy Adamski, Ton J. Rabelink, Jo G. R. De Mey, Anton Jan van Zonneveld*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)239-252
Number of pages14
JournalClinical Science
Volume133
Issue number2
DOIs
Publication statusPublished - 31 Jan 2019

Keywords

  • NATRIURETIC PEPTIDE
  • RENAL FIBROSIS
  • L-CARNITINE
  • PPAR-GAMMA
  • MECHANISMS
  • PATHWAY
  • ALPHA
  • INFLAMMATION
  • ALBUMINURIA
  • EXPRESSION

Cite this

Bijkerk, R., Aleksinskaya, M. A., Duijs, J. M. G. J., Veth, J., Husen, B., Reiche, D., Prehn, C., Adamski, J., Rabelink, T. J., De Mey, J. G. R., & van Zonneveld, A. J. (2019). Neutral endopeptidase inhibitors blunt kidney fibrosis by reducing myofibroblast formation. Clinical Science, 133(2), 239-252. https://doi.org/10.1042/CS20180882